Clinician Perceptions of the Negative Impact of Telehealth Services in the Management of Drug-Induced Movement Disorders and Opportunities for Quality Improvement: A 2021 Internet-Based Survey.
Rimal BeraMorgan BronBetsy BenningSamantha CiceroHeintje CalaraDiane DarlingEricha FraneyKendra MartelloCharles YonanPublished in: Neuropsychiatric disease and treatment (2022)
Our study highlights specific limitations and challenges and provides considerations to help clinicians better manage DIMDs in the context of telehealth services.